{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T01:59:24Z","timestamp":1781747964897,"version":"3.54.5"},"reference-count":14,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T00:00:00Z","timestamp":1283299200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T00:00:00Z","timestamp":1283299200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1016\/j.jneuroim.2010.07.005","type":"journal-article","created":{"date-parts":[[2010,8,12]],"date-time":"2010-08-12T04:56:28Z","timestamp":1281588988000},"page":"177-180","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"title":["Anti-SOX1 antibodies in patients with paraneoplastic and non-paraneoplastic neuropathy"],"prefix":"10.1016","volume":"226","author":[{"given":"M.","family":"Tschernatsch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Gross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Gerriets","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Kneifel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Probst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Malas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Kaps","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Blaes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2010.07.005_bb0005","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1136\/jnnp.67.1.7","article-title":"Carcinoma associated paraneoplastic peripheral neuropathies in patients with and without anti-onconeural antibodies","volume":"67","author":"Antoine","year":"1999","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jneuroim.2010.07.005_bb0010","first-page":"318","article-title":"Paraneoplastic syndromes affecting the nervous system","volume":"24","author":"Dalmau","year":"1997","journal-title":"Semin Oncol"},{"key":"10.1016\/j.jneuroim.2010.07.005_bb0015","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/00005792-199203000-00001","article-title":"Anti-Hu\u2014associated paraneoplastic encephalomyelitis\/sensory neuronopathy. A clinical study of 71 patients","volume":"71","author":"Dalmau","year":"1992","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jneuroim.2010.07.005_bb0020","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1136\/jnnp.2003.034447","article-title":"Recommended diagnostic criteria for paraneoplastic neurological syndromes","volume":"75","author":"Graus","year":"2004","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jneuroim.2010.07.005_bb0025","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.jneuroim.2005.03.020","article-title":"Anti-glial nuclear antibody: marker of lung cancer-related paraneoplastic neurological syndromes","volume":"165","author":"Graus","year":"2005","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.jneuroim.2010.07.005_bb0030","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1136\/jnnp.61.3.270","article-title":"Antibodies to a subpopulation of glial cells and a 66kDa developmental protein in patients with paraneoplastic neurological syndromes","volume":"61","author":"Honnorat","year":"1996","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jneuroim.2010.07.005_bb0035","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1002\/ana.410180513","article-title":"Autoimmune response of patients with paraneoplastic cerebellar degeneration to a Purkinje cell cytoplasmic protein antigen","volume":"18","author":"Jaeckle","year":"1985","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jneuroim.2010.07.005_bb0040","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1212\/01.wnl.0000281663.81079.24","article-title":"SOX1 antibodies are markers of paraneoplastic Lambert Eaton myasthenic syndrome","volume":"70","author":"Sabater","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2010.07.005_bb0045","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1196\/annals.1405.030","article-title":"Lambert\u2013Eaton myasthenic syndrome: tumor versus nontumor forms","volume":"1132","author":"Titulaer","year":"2008","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.jneuroim.2010.07.005_bb0050","doi-asserted-by":"crossref","first-page":"4260","DOI":"10.1200\/JCO.2008.20.6169","article-title":"SOX antibodies in small-cell lung cancer and Lambert\u2013Eaton myasthenic syndrome: frequency and relation with survival","volume":"27","author":"Titulaer","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jneuroim.2010.07.005_bb0055","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.1002\/cncr.21088","article-title":"Frequency of SOX Group B (SOX1, 2, 3) and ZIC2 antibodies in Turkish patients with small cell lung carcinoma and their correlation with clinical parameters","volume":"103","author":"Vural","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.jneuroim.2010.07.005_bb0060","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0140-6736(64)91694-0","article-title":"Serological findings in carcinomatous neuromyopathy","volume":"41","author":"Wilkinson","year":"1964","journal-title":"Lancet"},{"key":"10.1016\/j.jneuroim.2010.07.005_bb0065","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1046\/j.0022-7722.2002.00021.x","article-title":"Cytodifferentiation of Bergmann glia and its relationship with Purkinje cells","volume":"77","author":"Yamada","year":"2002","journal-title":"Anat Sci Int"},{"key":"10.1016\/j.jneuroim.2010.07.005_bb0070","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1002\/1531-8249(20010201)49:2<146::AID-ANA34>3.0.CO;2-E","article-title":"CRMP-5 neuronal autoantibody: marker of lung cancer and thymoma-related autoimmunity","volume":"49","author":"Yu","year":"2001","journal-title":"Ann Neurol"}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572810002961?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572810002961?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:16:08Z","timestamp":1759047368000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572810002961"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9]]},"references-count":14,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2010,9]]}},"alternative-id":["S0165572810002961"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2010.07.005","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2010,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-SOX1 antibodies in patients with paraneoplastic and non-paraneoplastic neuropathy","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2010.07.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}